Friday, 17 May 2024

SAB: Still at a discount after discounting its discounted valuation.

At RM3.60 per share, Southern Acids (M) Berhad (KLSE:5134) is valued at RM493m.

The company has been profitable for the past 20 years, except for FY09. Although a constant annual dividend of 5sen/share since FY14 isn’t particularly exciting, it has consistently paid dividends for at least 20 years. Additionally, it boasts a very solid balance sheet with net cash in excess of RM300m.  

SAB operates in 3 core businesses:

1)        oleochemical manufacturing

2)        healthcare services

3)        milling & cultivation.

However, the crown jewel of the group lies in its 260.82ha of freehold land. This land is strategically located between the matured township of Kota Kemuning and ongoing township developments of Bandar Rimbayu (IJM), Eco Sanctuary (Ecoworld), TwentyFive.7 (Gamuda) and Tropicana Aman (Tropicana).


Let’s estimate the net realisable value of SAB’s key assets using sum-of-the-parts method. This calculation excludes other smaller assets such as:

1) a 2.4% stake in listed Paramount Corporation Berhad (RM5.09m based on closing price of RM1.22)

2) An office at Centro Tower with a book value of RM4.37m

3) 3.25 acres of industrial land in Klang with a book value of RM3.32m

4) A corporate office with a book value of RM2.67m.


 

Assumptions/ valuation*

Estimated amount* (RM’m)

260.82ha of freehold land at Thangamallay Estate

RM56.44 psf(1)

1,584.65

232-bed Sri Kota Hospital

PE multiple of 20x

(2)477.58

Cash

Excluding minority interests(3)

305.47

Milling and cultivation

PE multiple of 8x, 63% stake

(4)215.64

Oleochemical manufacturing

20% of net asset value  (31 December 2023)

25.61

 

TOTAL

2,608.95

(RM19.05/share)

*See appendix

To be realistic, discounts are applied to these assets/ businesses:

 

 

Discount

Estimated amount (RM’m)

260.82ha of freehold land at Thangamallay Estate

75% discount (common for property stocks). Also,
excluded potential value appreciation from connectivity to West Coast Expressway

396.16

232-bed Sri Kota Hospital

10% discount

429.83

Cash

20% discount

244.38

Milling and cultivation

Discount of 2x PE multiple

161.73

Oleochemical manufacturing

Zero value(5)

0.00

 

TOTAL

1,232.10

(RM9.00/share)

Applying a further 20% discount to the overall discounted valuation, we arrive at a total valuation of RM985.68m (RM7.20/share).

Despite this valuation, the share price still reflects a steep discount of approximately 50% after considering the discounted value.


Join Bursa Stock Talk Telegram Channel for stock/ market updates:

t.me/bursastocktalk

t.me/bursastocktalk

t.me/bursastocktalk


Appendix

 

(1) Ten year ago, in 2014, Gamuda purchased 104.1ha of leasehold agricultural land nearby for RM392.2m, or RM35 psf, with the intention of developing it into TwentyFive.7 township. (https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download/?name=EA_GA_Attachments&id=62463)


Assuming the land appreciates at a compounded average growth rate of 3% and applying a 20% premium for freehold land, it arrives at a land price of RM56.44 psf.              

(Leasehold properties typically cost 20% less than a similar freehold property. https://www.iproperty.com.my/guides/freehold-vs-leasehold-title-malaysia-what-property-buyers-should-know-64117) Conversely, freehold properties usually cost 25% more than a comparable leasehold property. When we exclude the building and compare freehold land to leasehold land, logically, the premium should be more than 25%. To be conservative, a premium of 20% is adopted.


(2) To be conservative, we use the lower of FY23 PBT (RM31.42m) and annualised FY24 PBT (9MFY24: RM28.356m). A corporate tax of 24% is applied to estimate the estimated annual net profit.

With a target PE multiple of 20x, this amounts to approximately RM2.06m per bed.

Reference:

Based on IHH’s offer for Ramsay Sime Darby Health Care, which had 1,375 operational beds as at last Tuesday, the joint venture between Ramsay Healthcare Ltd — one of the world’s largest hospital operators — and Sime Darby Bhd was valued at about RM4.12 million, or about US$1 million, per operational bed. (https://theedgemalaysia.com/article/ihhs-offer-ramsay-sime-darby-puts-spotlight-kpjs-undervaluation)

 

(3) 


As of end of FY23 (31 March 2023), the group was in a net cash position of RM383.48m. Since SAB owns a 63% stake in Indonesian subsidiaries, proportionately, 37% of the cash in Indonesian Rupiah is excluded as non-controlling interests.


(4) To be conservative, we use the lower of FY23 PBT (RM74.56m) and annualised FY24 PBT (9MFY24: RM42.79m). A corporate tax of 25% is applied to estimate the estimated annual net profit.


(5) The oleochemical manufacturing division was profitable in FY22. However, it incurred losses in FY23 and 9MFY24. To be conservative, zero value is assigned to the loss-making business.

Saturday, 11 May 2024

DLADY - Turning the Corner?

Page 16 of The Edge Malaysia (13 May – 19 May 2024) carries an article titled “Completion of Dutch Lady’s New Facility Sparks Anticipation of Higher Dividend”.

The share price of DLADY rallied in 2012 as the dividend for 2012 jumped from 80sen/share a year ago to 260sen/share. Between 2013 and 2018, the share price was traded between the band of RM40 to RM80 before the substantial cut in dividend payments (from at least RM2/share a year) to fund the construction of new plant in Bandar Enstek. Coupled with the surge in prices of raw materials, this has led to a significant decline in DLADY’s share price from 2019 to 2023.


With the prices of skimmed milk powder and whole milk powder normalising, the operating profit and margin of DLADY in 2H23 have somewhat recovered. 


If we annualise the adjusted operating profit for 2H23 (excluding accelerated depreciation and one-off items), it actually surpasses the yearly operating profit for 2011 to 2018. However, the share price of DLADY is still trading below the RM40 to RM80 range, probably because of lower dividends and the earnings being masked by accelerated depreciation and one-off items.


# In line with the earlier announced investment in its future manufacturing activities, DLADY continued the accelerated depreciation of its assets in the Petaling Jaya factory that cannot be transitioned to the new site. As the construction of the state-of-the-art IR4.0 manufacturing facility in Bandar Enstek progresses, other one-off operating costs related to activities for the construction and transition towards the new site are incurred.

More importantly, DLADY has been gaining market share in Malaysia and experiencing volume growth in recent years.

The state-of-the-art IR4.0 plant in Bandar Enstek will double the capacity of the existing plant in PJ, with a room to further double the capacity (4x of PJ capacity). 

The new plant in Bandar Enstek is expected to be operational by end-2024. Usually a new plant will need to go through the gestation period before profit and dividends normalise. 

When the new plant, with a 100% increase in capacity, runs at optimal utilisation, what will be the profit, annual dividend and share price?